Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+1625.2%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+1625.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5135.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$7.29M+475.5%
2024$1.27M+102753.9%
2023$1231.00-13.2%
2022$1419.00-
2021$0.00-